Evidence map›Paper›PMID 23152297›Full record

ArticleAmerican journal of physiology. Renal physiology2013

An Af9 cis-element directly targets Dot1a to mediate transcriptional repression of the αENaC gene.

Wenzheng Zhang, Zhiyuan Yu, Hongyu Wu, Lihe Chen, Qun Kong, Bruce C Kone

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Epithelial Na+ Channels, Immune Cells, and Salt.Annual review of physiology · 2025
    Review
  2. A novel role of DOT1L in kidney diseases.Molecular biology reports · 2023
    Review
  3. Aldosterone inhibits Dot1l expression in guinea pig cochlea.European journal of medical research · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Regulation of αENaC transcription.Vitamins and hormones · 2015
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Development and Diseases of the Collecting Duct System.Results and problems in cell differentiation
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wenzheng ZhangDivision of Renal Diseases and Hypertension, The University of Texas Medical School at Houston, Houston, TX 77030, USA.
Zhiyuan Yu
Hongyu Wu
Lihe Chen
Qun Kong
Bruce C Kone
The University of Texas at Austin · USThe University of Texas Health Science Center at Houston · US

Funding

Regulation of ENaC TranscriptionR01DK075065 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KONE, BRUCE C. · 2006 to 2013
$2.5M
Epigenic Control of ENaC Transcription and Sodium TransportR01DK080236 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ZHANG, WENZHENG · 2009 to 2016
$2.2M
Aldosterone-sensitive repression of ENaC by AF9 and Dot1K01DK070834 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ZHANG, WENZHENG · 2005 to 2008
$330k
NIDDK NIH HHS K01 DK070834NIDDK NIH HHS K01 DK70834NIDDK NIH HHS R01 DK075065NIDDK NIH HHS R01 DK080236
6 · The paper itself

Abstract

The epithelial Na(+) channel subunit-α (αENaC) of the distal nephron is essential for salt balance. We previously demonstrated that the histone methyltransferase Dot1a and its protein partner Af9 basally repress αENaC transcription in mouse inner medullary collecting duct type 3 (mIMCD3) cells and link aldosterone-elicited chromatin modifications to αENaC transcriptional activation. Af9 DNA-binding activity has never been demonstrated, and whether and where Af9 binds to the αENaC promoter to target Dot1a are unknown. The present study sought to identify functional Af9 cis-element(s) in the -57/+439 "R3" subregion of αENaC, the principal site for Dot1a-Af9 interaction, in mIMCD3 cells. We also exploited connecting tubule/collecting duct-specific Dot1l-deficient mice (Dot1l(AC)) to determine the impact of Dot1l inactivation on renal αENaC expression in vivo. mIMCD3 cell lines expressing αENaC promoter-reporter constructs harboring deletion of +74/+107 demonstrated greatly reduced association of Af9 and Dot1a by ChIP/qPCR. Aldosterone treatment resulted in further decrements in Af9 and Dot1a association with the αENaC promoter. Gel shift and antibody competition assays using wild-type and mutant oligomers revealed Af9-containing +78/+92 αENaC DNA-protein complexes in nuclear extracts of mIMCD3 cells. Mutation of the +78/+92 element resulted in higher basal αENaC promoter activity and impaired Dot1a-mediated inhibition in trans-repression assays. In agreement, mice with connecting tubule/collecting duct-specific knockout of Dot1l exhibited greater αENaC mRNA levels in kidney compared with control. Thus, we conclude that +78/+92 of αENaC represents the primary Af9 binding site involved in recruiting Dot1a to repress basal and aldosterone-sensitive αENaC transcription and that Dot1l inactivation promotes αENaC mRNA expression by eliminating Dot1a-mediated repression.

Indexed as

Epigenetic RepressionTranscription, GeneticAldosteroneAnimalsCell LineEpithelial Sodium ChannelsFemaleHistone-Lysine N-MethyltransferaseKidney Tubules, CollectingMaleMethyltransferasesMiceMice, KnockoutMutationNuclear ProteinsPromoter Regions, GeneticAldosteroneDot1l protein, mouseEpithelial Sodium ChannelsHistone-Lysine N-MethyltransferaseMethyltransferasesMllt3 protein, mouseNuclear ProteinsScnn1a protein, mouse

Identifiers

PMID23152297
PMCPMC3566494
OpenAlexW2056771590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.